why choose us

First received: September 27, 2022

Clinical Trial: Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gynecologic Cancer

Study Type: INTERVENTIONAL


Official Title: Evaluation of a Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment in an Underserved Gynecology Population

Brief Summary: In this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual care' that patients would receive.This comparison will enable the investigators to determine if the chatbot system can improve rates of recommendation for genetic testing among patients at elevated risk of harboring a familial cancer syndrome in an all-Medicaid gynecology clinic.Furthermore, the…

Read more